a developer of therapeutic products for cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, GERN has been loosely correlated with SER. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if GERN jumps, then SER could also see price increases.
Ticker / NAME | Correlation To GERN | 1D Price Change % | ||
---|---|---|---|---|
GERN | 100% | -2.52% | ||
SER - GERN | 65% Loosely correlated | -3.66% | ||
OTLK - GERN | 43% Loosely correlated | -4.94% | ||
SCPH - GERN | 36% Loosely correlated | -0.51% | ||
XNCR - GERN | 34% Loosely correlated | -0.42% | ||
MGTX - GERN | 33% Loosely correlated | +5.71% | ||
More |
Ticker / NAME | Correlation To GERN | 1D Price Change % |
---|---|---|
GERN | 100% | -2.52% |
GERN (2 stocks) | 54% Loosely correlated | -0.48% |
cancer (82 stocks) | 31% Poorly correlated | -2.38% |
drugs (254 stocks) | 30% Poorly correlated | -1.72% |
therapeutics (53 stocks) | 25% Poorly correlated | -2.44% |
biotechnology (238 stocks) | 22% Poorly correlated | -1.80% |